Pharmacodynamics Practice Questions
20 free Pharmacodynamics practice questions for the Pharmacology, each with the correct answer and a detailed explanation. Open any question below, or take the full set as an interactive quiz.
Questions
20 questions
All Pharmacodynamics questions
- Q1. Which term describes the concentration of a drug required to produce 50% of its maximum effect?
- Q2. A drug that binds to a receptor and produces a submaximal response, even at high concentrations, is known as a:
- Q3. In the presence of a competitive antagonist, how does the log dose-response curve of an agonist change?
- Q4. Which of the following describes an 'Inverse Agonist'?
- Q5. The 'Therapeutic Index' (TI) of a drug is calculated as the ratio of:
- Q6. Which receptor type typically mediates the fastest physiologic responses (millisecond timescale)?
- Q7. Which signaling molecule is primarily associated with the activation of the Gq protein pathway?
- Q8. Non-competitive antagonists decrease the maximal efficacy ($E_{max}$) of an agonist because:
- Q9. What occurs during the process of receptor 'Down-regulation'?
- Q10. Which of the following is an example of 'Functional Antagonism'?
- Q11. A 'Spare Receptor' population exists when:
- Q12. The binding of a drug to a receptor is typically governed by which type of chemical bond to ensure reversibility?
- Q13. Which statement best describes 'Tachyphylaxis'?
- Q14. The 'Intrinsic Activity' of a competitive antagonist is:
- Q15. Which of the following receptor types functions by translocating to the nucleus to regulate gene transcription?
- Q16. If Drug A has an ED50 of 5 mg and Drug B has an ED50 of 50 mg, and both reach the same Emax, which is true?
- Q17. The activation of Adenylate Cyclase, leading to increased cAMP, is the characteristic effect of which G-protein?
- Q18. What does a 'Quantal Dose-Response' curve represent?
- Q19. Which term describes a genetically determined abnormal or unusual response to a drug?
- Q20. Which of the following is a classic example of a drug acting through an extracellular enzyme rather than a membrane receptor?